Luxembourg Centre for Systems Biomedicine Appoints BIOBASE Genome Trax™ to Identify Human Genome Variations
News Jul 18, 2012
In addition, both groups will collaborate to establish a hub of expertise for the application of BIOBASE products and will provide data analysis, training, and support to researchers in Luxembourg and surrounding countries.
Genome Trax™ prioritizes human genome variants in whole genome or exome data that merit further investigation. The tool maps NGS data to known features such as disease mutations and regulatory sites. In addition, Genome Trax™ identifies novel mutations that are likely to affect the function of candidate disease genes, and enables users to filter out the millions of irrelevant variants.
Reinhard Schneider, Head of the Bioinformatics core facility at the LCSB, stated: “The mutation, regulation and pharmacogenomics data in Genome Trax™ are crucial for the annotation of our clinical data. These annotations are unparalleled in their comprehensiveness and quality, and I see this collaboration as a strategic partnership to advance the clinical application of NGS technology”.
"The LCSB is turning into one of the leading centers for bioinformatics worldwide and the bioinformatics facility, led by Dr. Reinhard Schneider, needs to interpret large volumes of data from the life sciences. This undertaking is powered by massive hardware, and needs the best available software and databases. LCSB chose BIOBASE as a strategic partner and I am looking forward to this collaboration.” said Frank Schacherer, CTO of BIOBASE.
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.